In this study, we want to learn more about how people understand sentences on a computer screen. We are looking for English speakers who only speak one language and have no trouble reading or speaking. We will see if there are any differences in how people understand them.

Are you interested in improving your physical health and wellbeing during or after cancer treatment? If so, our free 12- week exercise program might be a good fit for you! We are creating a registry of adults with a cancer diagnosis who have gone through our program.

The purpose of this study is to see if batoclimab is safe and helps people with chronic inflammatory demyelinating polyneuropathy (CIDP), an autoimmune disorder. Batoclimab is also known as IMVT-1401. Batoclimab is injected under the skin (subcutaneously) and targets the immune system.

Have you recently had an anterior cruciate ligament injury and will be undergoing anterior cruciate ligament reconstruction surgery? If so, you may be able to participate in a study comparing the effects on pain relief and arthritis prevention of metformin or placebo. Compensation provided.

Do you have triple-negative breast cancer that either came back or did not improve after initial cancer treatment? If so, you may be able to take part in this gene therapy research study to learn more about using your own modified immune cells as a possible treatment.

Can we extend your life after the diagnosis of your cancer in the stomach, esophagus, or gastroesophageal junction by adding a third chemotherapy drug to the usual combination of two chemotherapy drugs? We are doing this study because we want to find out if this approach is better or worse than the usual approach for treatment of your cancer in the stomach, esophagus, or gastroesophageal junction. The usual approach is defined as care most people get for cancer in the stomach, esophagus, or gastroesophageal junction.

Do you have Stage II or III Breast cancer? If you have enough tissue from your breast cancer diagnosis to send for Mammaprint genomic testing, you may be able to take part in this research study. In this study, we want to learn more about adding an immunotherapy drug, durvalumab, to your chemotherapy treatment. The Mammaprint testing is conducted at no cost to you and the cost of durvalumab is covered.

Have you been diagnosed with Blood Cancer. If so, you may be able to take part in a research study looking at the safety of giving a new drug called AZD9829 to patients with Leukemia.

This is a research study to compare the safety and effectiveness of two different ways to treat asthma. The first way is adding inhaled corticosteroids to your rescue medication (the medicine that opens your airways quickly). The second way it using an antibiotic over time. These treatments will be used alone or together and compared to usual care plus a system to track asthma symptoms at home. We hope to find out who will do best with each type of treatment, which is not known at this time.

Are you a young adult cancer survivor who would like to lose weight? Interested in using technology to support a healthy diet, get more physically active, and improve your mental health? Researchers at the University of North Carolina at Chapel Hill are looking for volunteers to sign up for a 6-month research program that will involve using a Fitbit activity tracker, digital smart scale, and mobile app. For more information and to see if you qualify, visit our study website at www.uncweightresearch.org